Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Chieregato GC and Leoni A Treatment of psoriatic arthropathy with etretinate: a two-year follow-up. 1986 Acta Derm. Venereol. pmid:2430403
Liang R Thrombocytopenia associated with etretinate therapy. 1988 Acta Haematol. pmid:3124469
Dreno B et al. Roferon-A in combination with Tigason in cutaneous T-cell lymphomas. 1993 Acta Haematol. pmid:8475670
Roth AD et al. High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas. 1999 Acta Oncol pmid:10427950
Granström G and Tjellström A Ear deformities in mandibulofacial dysostosis. 1992 Acta Otolaryngol Suppl pmid:1636410
Jakubowicz K et al. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis. 1986 Acta Univ Carol Med (Praha) pmid:3324721
Misset JL et al. Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment. 1985 Acta Vitaminol. Enzymol. pmid:3842228
Grasa MP et al. [Hypertrophic Darier's disease of unusual intensity. Enzymatic and ultrastructural study and therapeutic response]. 1981 Nov-Dec Actas Dermosifiliogr pmid:7344430
Nolibe D et al. Effect of chronic administration of a synthetic aromatic retinoid (Ro 10-9359) on the development of lung squamous metaplasia and epidermoid cancer in rats. 1983 Adv. Exp. Med. Biol. pmid:6650282
Peñas PF et al. Dermatologic treatment of cutaneous graft versus host disease. 2004 Am J Clin Dermatol pmid:15663337